Article ID Journal Published Year Pages File Type
6087208 Clinical Immunology 2015 8 Pages PDF
Abstract
In conclusion, one week of treatment with anakinra improves insulin sensitivity in patients with type 1 diabetes.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Immunology
Preview
One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus
Authors
, , , , , ,